Merry Christmas everyone. 2013 should be a landmark year for us. Profitability on 10 fda approved drugs plus a few other products hitting approvals. Abuse resistant products completing studies and sale of Novel. I expect that by the end of 2013, this company will be seen in a whole different light by the market and those that understand the business plan being executed will reap the benefits. Best to you and your families.

I am not joking or kidding when I say I expect to retire off of my investment here. Revenue is revenue, products are products, abuse resistant tech in a 20B market, and leadership wholly invested in the future.